2024-06-14 CALL at $205.0 Option on Biogen Inc
| BIIB Stock | USD 224.94 4.87 2.21% |
2024-06-14 CALL at $205.0 is a CALL option contract on Biogen's common stock with a strick price of 205.0 expiring on 2024-06-14. The contract was not traded in recent days and, as of today, has 13 days remaining before the expiration. The option is currently trading at a bid price of $16.8, and an ask price of $24.2. The implied volatility as of the 1st of June is 28.19.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Biogen |
Call options on Biogen give the investor right to buy Biogen Stock at a specified price within a specific period. The strike price represents the predetermined price at which a call buyer can buy Biogen Stock. Call options may be purchased for speculation or sold for income purposes, or simply combined for various spread or combination strategies. If Biogen's price is above the strike price at expiry, the profit is the current Biogen's stock price, minus the strike price and the premium.
Rule 16 of 2024-06-14 Option Contract
The options market is anticipating that Biogen Inc will have an average daily up or down price movement of about 1.76% per day over the life of the option. With Biogen trading at USD 224.94, that is roughly USD 3.96. If you think that the market is fully understating Biogen's daily price movement you should consider buying Biogen Inc options at that current volatility level of 28.19%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Call Option on Biogen
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Biogen positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Biogen Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
| Call Contract Name | 2024-06-14 CALL at $205.0 |
| Expires On | 2024-06-14 |
| Days Before Expriration | 13 |
| Last Traded On | 0000-00-00 00:00:00 |
| Contract Period | WEEKLY |
| Open Interest | 0 |
| Current Trading Volume | 0.0 |
| Strike Price | 205.0 |
| Last Traded At | 0.0 |
| Current Price Spread | 16.8 | 24.2 |
| Rule 16 Daily Up or Down | USD3.96 |
Biogen short CALL Option Greeks
Biogen's Option Greeks for the contract ending on 2024-06-14 at a strike price of 205.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Biogen's option greeks, its implied volatility helps estimate the risk of Biogen stock implied by the prices of the options on Biogen's stock.
| Delta | 0.9646 | |
| Gamma | 0.0065 | |
| Theta | -0.0646 | |
| Vega | 0.0331 | |
| Rho | 0.07 |
Biogen long CALL Option Payoff at expiration
Buying Biogen's call option is the simplest of option trades. A call option on Biogen Stock gives investors the right (but not the obligation) to purchase Biogen at the given strike price. Therefore Biogen's call intrinsic value or payoff at expiration depends on where the Biogen Stock price is relative to the call option strike price. The strike price of 205.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with Biogen's price. Finally, at the break-even point of 225.5, the line crosses zero, and trading Biogen becomes profitable.
Profit |
| Biogen Price At Expiration |
Biogen short CALL Option Payoff at expiration
By selling Biogen's call option, the investors signals his or her bearish sentiment. A short position in a call option written on Biogen will generally make money when the underlying price goes down. Therefore Biogen's call intrinsic value or payoff at expiration depends on where the Biogen Stock price is relative to the call option strike price. The strike price of 205.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to Biogen's price. Finally, at the break-even point of 225.5, the line crosses zero, and trading Biogen becomes disadvantageous with no downside limits.
Profit |
| Biogen Price At Expiration |
Biogen Inc Available Call Options
Biogen's option chain is a display of a range of information that helps investors for ways to trade options on Biogen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biogen. It also shows strike prices and maturity days for a Biogen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-07 CALL at $125.0 | 0.9247 | 0.0013 | 0 | 2024-06-07 | 95.1 - 104.7 | 0.0 | In |
Call | 2024-06-07 CALL at $130.0 | 0.9187 | 0.0014 | 0 | 2024-06-07 | 90.1 - 99.9 | 0.0 | In |
Call | 2024-06-07 CALL at $135.0 | 0.915 | 0.0016 | 0 | 2024-06-07 | 85.0 - 94.8 | 0.0 | In |
Call | 2024-06-07 CALL at $140.0 | 0.9111 | 0.0017 | 0 | 2024-06-07 | 80.0 - 89.7 | 0.0 | In |
Call | 2024-06-07 CALL at $145.0 | 0.9058 | 0.0019 | 0 | 2024-06-07 | 75.0 - 84.7 | 0.0 | In |
Call | 2024-06-07 CALL at $150.0 | 0.9002 | 0.0021 | 0 | 2024-06-07 | 70.0 - 79.7 | 0.0 | In |
Call | 2024-06-07 CALL at $155.0 | 0.8919 | 0.0023 | 0 | 2024-06-07 | 65.0 - 74.9 | 0.0 | In |
Call | 2024-06-07 CALL at $160.0 | 0.8863 | 0.0026 | 0 | 2024-06-07 | 60.1 - 69.8 | 0.0 | In |
Call | 2024-06-07 CALL at $165.0 | 0.8789 | 0.0029 | 0 | 2024-06-07 | 55.1 - 64.8 | 0.0 | In |
Call | 2024-06-07 CALL at $170.0 | 0.8708 | 0.0033 | 0 | 2024-06-07 | 50.0 - 59.8 | 0.0 | In |
Call | 2024-06-07 CALL at $175.0 | 0.8603 | 0.0037 | 0 | 2024-06-07 | 45.0 - 54.9 | 0.0 | In |
Call | 2024-06-07 CALL at $180.0 | 0.8499 | 0.0042 | 0 | 2024-06-07 | 40.0 - 49.9 | 0.0 | In |
Call | 2024-06-07 CALL at $185.0 | 0.8382 | 0.0049 | 0 | 2024-06-07 | 35.3 - 44.9 | 0.0 | In |
Call | 2024-06-07 CALL at $190.0 | 0.8245 | 0.0056 | 0 | 2024-06-07 | 30.1 - 39.9 | 35.0 | In |
Call | 2024-06-07 CALL at $192.5 | 0.9918 | 0.0015 | 0 | 2024-06-07 | 28.0 - 37.3 | 0.0 | In |
Call | 2024-06-07 CALL at $195.0 | 0.8101 | 0.0066 | 0 | 2024-06-07 | 25.2 - 34.8 | 0.0 | In |
Call | 2024-06-07 CALL at $197.5 | 0.8101 | 0.0073 | 0 | 2024-06-07 | 23.0 - 31.8 | 0.0 | In |
Call | 2024-06-07 CALL at $200.0 | 0.7945 | 0.0079 | 1 | 2024-06-07 | 20.6 - 29.6 | 19.1 | In |
Call | 2024-06-07 CALL at $202.5 | 0.8023 | 0.0091 | 0 | 2024-06-07 | 18.5 - 26.2 | 0.0 | In |
Call | 2024-06-07 CALL at $205.0 | 0.7878 | 0.0101 | 4 | 2024-06-07 | 16.0 - 23.8 | 14.03 | In |
Call | 2024-06-07 CALL at $207.5 | 0.7738 | 0.0114 | 0 | 2024-06-07 | 13.6 - 21.3 | 0.0 | In |
Call | 2024-06-07 CALL at $210.0 | 0.7966 | 0.0142 | 2 | 2024-06-07 | 12.2 - 17.5 | 9.4 | In |
Call | 2024-06-07 CALL at $212.5 | 0.9881 | 0.0054 | 3 | 2024-06-07 | 10.4 - 14.9 | 3.65 | In |
Call | 2024-06-07 CALL at $215.0 | 0.7256 | 0.018 | 8 | 2024-06-07 | 6.5 - 13.4 | 6.6 | In |
Call | 2024-06-07 CALL at $217.5 | 0.8612 | 0.0305 | 16 | 2024-06-07 | 6.9 - 10.3 | 8.15 | In |
Call | 2024-06-07 CALL at $220.0 | 0.7928 | 0.0442 | 39 | 2024-06-07 | 3.7 - 8.1 | 4.2 | In |
Call | 2024-06-07 CALL at $222.5 | 0.637 | 0.0471 | 22 | 2024-06-07 | 4.6 - 5.5 | 4.65 | In |
Call | 2024-06-07 CALL at $225.0 | 0.5139 | 0.0492 | 31 | 2024-06-07 | 3.3 - 4.1 | 3.3 | Out |
Call | 2024-06-07 CALL at $227.5 | 0.3968 | 0.046 | 11 | 2024-06-07 | 1.95 - 6.5 | 2.31 | Out |
Call | 2024-06-07 CALL at $230.0 | 0.3032 | 0.0389 | 34 | 2024-06-07 | 1.3 - 1.8 | 1.7 | Out |
Call | 2024-06-07 CALL at $232.5 | 0.226 | 0.0321 | 5 | 2024-06-07 | 0.5 - 3.6 | 1.2 | Out |
Call | 2024-06-07 CALL at $235.0 | 0.168 | 0.0256 | 13 | 2024-06-07 | 0.0 - 1.0 | 0.86 | Out |
Call | 2024-06-07 CALL at $237.5 | 0.1222 | 0.02 | 5 | 2024-06-07 | 0.05 - 0.6 | 0.6 | Out |
Call | 2024-06-07 CALL at $240.0 | 0.0712 | 0.0141 | 19 | 2024-06-07 | 0.0 - 2.25 | 0.3 | Out |
Call | 2024-06-07 CALL at $250.0 | 0.0233 | 0.0047 | 0 | 2024-06-07 | 0.0 - 0.2 | 0.1 | Out |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Biogen Corporate Executives
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael CPA | Executive CFO | Profile |
Already Invested in Biogen Inc?
The danger of trading Biogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 8.01 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.